ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,994.29
0.08%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Celyad Oncology SA (CYAD)

  7. Celyad Oncology SA (CYAD) Noticias

CYAD

Celyad Oncology (CYAD)

Celyad Oncology SA
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CYAD
FechaHoraFuenteTítuloSímboloCompañía
04/04/202400:00Business WireCelyad Oncology publie ses résultats financiers pour l'année 2023 ainsi que les récents évènements marquantsNASDAQ:CYADCelyad Oncology SA
04/04/202400:00Business WireCelyad Oncology Reports Full Year 2023 Financial Results and Recent Business HighlightsNASDAQ:CYADCelyad Oncology SA
08/02/202415:01Business WireCelyad Oncology annonce son intention de mettre fin à ses obligations de déclaration à la SECNASDAQ:CYADCelyad Oncology SA
08/02/202415:01Business WireCelyad Oncology Announces Intention to Terminate SEC Reporting ObligationsNASDAQ:CYADCelyad Oncology SA
17/01/202405:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYADCelyad Oncology SA
16/01/202415:01Business WireCelyad Oncology Provides Fourth Quarter 2023 Business Update and 2024 OutlookNASDAQ:CYADCelyad Oncology SA
16/01/202415:01Business WireCelyad Oncology fait le point sur les activités du quatrième trimestre 2023 et présente ses perspectives pour 2024NASDAQ:CYADCelyad Oncology SA
20/12/202315:01Business WireCelyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
20/12/202315:01Business WireCelyad Oncology SA : Publication d’une notification de transparence de Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
15/12/202315:01Business WireCelyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)NASDAQ:CYADCelyad Oncology SA
15/12/202315:01Business WireCelyad Oncology SA : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la Loi du 2 Mai 2007)NASDAQ:CYADCelyad Oncology SA
04/12/202307:34Business WireCelyad Announces Management ChangeNASDAQ:CYADCelyad Oncology SA
04/12/202307:34Business WireCelyad annonce un changement de directionNASDAQ:CYADCelyad Oncology SA
30/11/202315:01Business WireCelyad Oncology SA : Publication d’une notification de transparence reçue de Tolefi SA (Article 14 §1 de la loi du 2 mai 2007)NASDAQ:CYADCelyad Oncology SA
30/11/202315:01Business WireCelyad Oncology SA: Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)NASDAQ:CYADCelyad Oncology SA
21/11/202315:00Business WireCelyad Oncology SA: Publication of a transparency notification received from Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
09/11/202300:00Business WireCelyad Oncology publie ses résultats financiers pour le troisième trimestre de 2023 ainsi que ses récentes avancéesNASDAQ:CYADCelyad Oncology SA
09/11/202300:00Business WireCelyad Oncology reports third quarter 2023 financial results and recent business highlightsNASDAQ:CYADCelyad Oncology SA
25/09/202315:01Business WireCelyad Oncology Announces the Termination of Its American Depository Receipt ProgramNASDAQ:CYADCelyad Oncology SA
25/09/202315:01Business WireCelyad Oncology annonce l’arrêt de son programme d’American Depositary ReceiptNASDAQ:CYADCelyad Oncology SA
15/09/202315:01Business WireCelyad Oncology SA : Publication d’une notification de transparence rectifiée de Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
15/09/202315:01Business WireCelyad Oncology SA: Publication of a Rectified Transparency Notification Received From Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
12/09/202315:01Business WireCelyad Oncology SA : Publication d’une notification de transparence reçue de Tolefi SANASDAQ:CYADCelyad Oncology SA
12/09/202315:01Business WireCelyad Oncology SA: Publication of a Transparency Notification Received from Tolefi SANASDAQ:CYADCelyad Oncology SA
07/09/202315:01GlobeNewswire Inc.Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)NASDAQ:CYADCelyad Oncology SA
07/09/202315:01Business WireCelyad Oncology SA : Notification de transparence de Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
05/09/202315:00Business WireCelyad Oncology SA: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)NASDAQ:CYADCelyad Oncology SA
05/09/202315:00GlobeNewswire Inc.Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)NASDAQ:CYADCelyad Oncology SA
04/09/202315:00GlobeNewswire Inc.Celyad Oncology Reports First Half 2023 Financial Results and Recent Business HighlightsNASDAQ:CYADCelyad Oncology SA
04/09/202315:00Business WireCelyad Oncology Présente ses Résultats Financiers pour le Premier Semestre de l’année 2023 et les Récents Evénements Marquants de son ActivitéNASDAQ:CYADCelyad Oncology SA
 Showing the most relevant articles for your search:NASDAQ:CYAD

Su Consulta Reciente

TSXV
MXR
Max Resource
COIN
ELTCOINETH
ELTCOIN
TG
HNRA
Hannover Rueck
LSE
0A7Z
Orbcomm
USOTC
EESI
Encompass Energy Services (CE)
LSE
FASA
Ivz A Shr Esg A
BIT
UC277A
Unicredit Bank
UNSW
SDAOETH
Singularity Dao
UNSW3
STARETH
Starbase
DBI
DH57
Leverage DAX X5 Total Re...
TSX
ISCB
IA Clarington Strategic ...
EU
IWEL8
AMUNDI WEL8 INAV
DGFX
WAGMIGAMESUSDT
WAGMI
NASDAQ
SPWRB
TIDE
HKNBTC
BIT
P1KP43
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados